Apellis Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc.（APLS）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
apls · 股价预测 · 25 位分析师（近3月）· FMP · 更新于 2026年5月20日
分析师评级与共识
基于过去 3 个月内 25 位华尔街分析师
Buy
25 位分析师
共识
评级分布
12 个月目标价
High
$48.00
Consensus
$33.40
-18.6% upside
Low
$19.00
Median: $35 · Last Close: $41.03
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$33.40
-18.6% upside
High Target
$48
17.0%
Low Target
$19
-53.7%
Current Price
$41.03
as of today
Based on analyst price targets, the APLS stock price prediction for the next 12 months ranges from $19 to $48. The consensus APLS price forecast of $33.40 implies -18.6% upside from the current price of $41.03.
短期股价预测
Ranging算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $41.02 | ↓ 0.02% |
1-day model range: $41.01–$41.03. Peak: $41.03 (-0.02%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · APLS · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2024-09-24 | Wells Fargo | Maintains | Equal Weight→Equal Weight |
| 2024-09-23 | Baird | Maintains | Outperform→Outperform |
| 2024-09-20 | Needham | Maintains | Buy→Buy |
| 2024-09-20 | Mizuho | Maintains | Neutral→Neutral |
| 2024-09-13 | JP Morgan | Maintains | Overweight→Overweight |
| 2024-08-13 | JP Morgan | Maintains | Overweight→Overweight |
| 2024-08-09 | Needham | Maintains | Buy→Buy |
| 2024-08-09 | Wedbush | Maintains | Neutral→Neutral |
| 2024-08-09 | Goldman Sachs | Maintains | Buy→Buy |
| 2024-08-09 | UBS | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Apellis Pharmaceuticals, Inc. (APLS) stock. Of the recent 187 rating actions, 9 were upgrades and 14 were downgrades. 25 analysts currently cover APLS.
分析师推荐趋势
APLS analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 4 to 3 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$871M
↓ 31.0% YoY
Revenue Next Year
$1.0B
↑ 17.8% YoY
EPS This Year
$-1.03
EPS Next Year
$-0.07
↓ 93.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast APLS EPS of $-1.03 for the current fiscal year, based on estimates from 8 analysts. The APLS revenue forecast is $871M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
APLS 股价预测由两类独立数据源支撑：来自 25 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。APLS 的共识目标价为 $33.40（-18.6% 上行空间），分析师共识为 Buy。
APLS 的短期预测（明日）为 $41.02（-0.02%）。
Apellis Pharmaceuticals, Inc. 在 NASDAQ 上市，代码 APLS。APLS 在 2027 年的整体展望偏积极，在覆盖分析师中约 72% 对应 Buy 共识。
常见问题
APLS 预测 · 8 个问题根据 25 位华尔街分析师，APLS 的 12 个月平均目标价为 $33.40，最高 $48.00、最低 $19.00。若有图表，中位目标价可在上方查看。相对当前价 $41.03，隐含约 -18.6% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.